Physician profile
Cynthia Frischmann
NPI 1346316635
$3,980.17
in general payments reported to CMS, 2019-2025
13 companies · $887 in 2025
The $887 reported for 2025 was more than what 94% of Vision Therapy providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $651 · 2020: $260 · 2021: $124 · 2022: $350 · 2023: $714 · 2024: $994 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,529 · Entertainment: $66.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,529.10 |
| Entertainment | $66.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,043.23 | 2022-2025 | Miebo, Xiidra, Infuse |
| Coopervision INC. | $609.55 | 2019-2025 | Misight Contact Lens, Onefit Contact Lens, Myday Contact Lens |
| Alcon Vision LLC | $475.59 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $441.41 | 2019 | |
| Sun Pharmaceutical Industries INC. | $301.44 | 2022-2024 | |
| Johnson & Johnson Vision Care, INC. | $238.36 | 2023-2025 | Acuvue |
| Dompe US, INC. | $219.55 | 2023-2024 | Oxervate |
| Mallinckrodt Hospital Products INC. | $129.06 | 2024 | Acthar |
| Tarsus Pharmaceuticals, INC. | $125.21 | 2025 | |
| Novartis Pharmaceuticals Corporation | $109.95 | 2020 | |
| Allergan, INC. | $103.03 | 2021 | |
| Glaukos Corporation | $96.66 | 2022 | |
| Optos, INC. | $87.13 | 2021-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Frischmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.